Sharescart Research Club logo
Products
Research
Tools
About
Join Channel
Consolidated Standalone

MK Proteins

₹6.5 -0.1 | 1.8%

Market Cap ₹243 Cr.

Stock P/E 28.9

P/B 3.3

Current Price ₹6.5

Book Value ₹ 1.9

Face Value 1

52W High ₹9.8

Dividend Yield 0%

52W Low ₹ 5.4

Edit Ratio

MK Proteins Research see more...

Overview Inc. Year: 2012Industry: Edible Oil

MK Proteins Ltd is a food manufacturing company based in India. Established in 1996, the company specializes in the production of soybean meal, which is used as animal feed. MK Proteins has a strong presence in the domestic and international markets, with a focus on Asia, Europe, and the Middle East. The company's state-of-the-art manufacturing facilities are located in Madhya Pradesh, India, and are equipped with modern machinery and technology to ensure high-quality products. MK Proteins is committed to sustainability and ethical business practices, and the company's soybean meal is made from non-genetically modified soybeans. With a dedicated team of professionals and a focus on innovation and customer satisfaction, MK Proteins is poised for continued growth and success in the global food industry.

Read More..

MK Proteins Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

MK Proteins Quarterly Results

#(Fig in Cr.) Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 76 14 69 87 57 34 39 137 115
Other Income 0 0 0 0 0 0 0 0 0
Total Income 76 14 69 87 57 34 40 137 115
Total Expenditure 72 13 65 78 54 31 38 133 109
Operating Profit 4 1 4 9 4 2 2 5 6
Interest 1 0 0 0 0 0 0 1 1
Depreciation 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0
Profit Before Tax 3 1 3 8 3 2 2 4 5
Provision for Tax 1 0 1 2 1 1 0 1 1
Profit After Tax 2 0 2 6 2 2 1 3 4
Adjustments -0 0 0 0 0 0 0 -0 0
Profit After Adjustments 2 0 2 6 2 2 1 3 4
Adjusted Earnings Per Share 0.1 0 0.1 0.2 0.1 0 0 0.1 0.1

MK Proteins Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 123 145 165 172 157 194 311 256 315 245 268 325
Other Income 0 0 0 0 0 0 0 0 1 0 0 0
Total Income 123 145 165 172 157 194 311 256 316 246 268 326
Total Expenditure 119 141 160 166 152 189 295 240 298 229 255 311
Operating Profit 4 4 5 6 5 5 16 16 18 17 13 15
Interest 2 2 2 2 2 2 1 1 2 1 1 2
Depreciation 1 1 1 1 1 1 1 1 1 1 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 2 2 2 2 14 14 15 15 11 13
Provision for Tax 0 0 1 1 1 1 4 4 4 4 3 3
Profit After Tax 1 1 1 1 2 2 10 10 11 11 8 10
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 1 1 1 2 2 10 10 11 11 8 10
Adjusted Earnings Per Share 0 0 0 0 0 0 0.3 0.3 0.3 0.3 0.2 0.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 9% 2% 7% 8%
Operating Profit CAGR -24% -7% 21% 13%
PAT CAGR -27% -7% 32% 23%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -31% -21% 49% NA%
ROE Average 13% 19% 26% 23%
ROCE Average 13% 17% 21% 15%

MK Proteins Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 3 3 4 15 17 19 29 40 50 61 69
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 7 8 12 12 2 4 4 3 3 0 1
Other Non-Current Liabilities 0 0 0 0 -0 -0 -0 -0 1 1 1
Total Current Liabilities 25 28 30 29 29 34 34 44 52 36 61
Total Liabilities 35 39 47 56 47 56 67 86 105 98 132
Fixed Assets 6 7 7 6 4 3 2 3 3 3 4
Other Non-Current Assets 0 0 0 0 0 0 0 0 1 7 8
Total Current Assets 29 32 39 50 42 53 64 82 101 88 120
Total Assets 35 39 47 56 47 56 67 86 105 98 132

MK Proteins Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities 11 -4 -4 -12 6 -4 6 -10 -6 32 -16
Cash Flow from Investing Activities -0 -2 -1 -0 0 0 -0 -2 0 -6 -1
Cash Flow from Financing Activities -10 6 5 12 -7 4 -5 12 6 -27 18
Net Cash Inflow / Outflow -0 0 -0 0 -0 0 -0 0 0 0 -0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 0 0

MK Proteins Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.03 0.03 0.04 0.04 0.04 0.05 0.28 0.27 0.29 0.3 0.22
CEPS(Rs) 0.06 0.07 0.09 0.07 0.08 0.08 0.3 0.3 0.31 0.31 0.23
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.1 0.13 0.16 0.41 0.46 0.5 0.78 1.06 1.33 1.63 1.85
Core EBITDA Margin(%) 3.38 2.92 3 3.21 3.2 2.48 5.14 6.06 5.4 6.78 4.66
EBIT Margin(%) 2.84 2.33 2.3 2.56 2.46 2.04 4.87 5.83 5.35 6.74 4.71
Pre Tax Margin(%) 0.99 0.72 0.92 1.28 1.46 1.26 4.6 5.49 4.75 6.29 4.27
PAT Margin (%) 0.68 0.5 0.6 0.83 1.05 0.94 3.34 3.98 3.47 4.56 3.13
Cash Profit Margin (%) 1.22 1.12 1.33 1.54 1.83 1.54 3.63 4.34 3.73 4.78 3.26
ROA(%) 2.48 1.94 2.3 2.78 3.18 3.51 16.83 13.32 11.45 11.04 7.3
ROE(%) 39.43 24.9 27.1 14.62 10.07 10.07 43.03 29.54 24.44 20.21 12.87
ROCE(%) 13.53 13.06 11.82 10.57 8.42 8.54 29.13 22.82 19.78 18.99 13.46
Receivable days 17.24 20.25 16.87 24.54 34.18 19.13 17.69 35.56 26.19 14.57 3.39
Inventory Days 60.14 52.77 59.12 67.28 69.12 64.25 44.99 62.38 69.99 111.73 129.74
Payable days 22.28 27.84 21.28 16.85 9.8 6.29 7.51 10.5 6.29 13.74 23.45
PER(x) 0 0 0 23.49 18.9 16.39 3.19 7.84 0 33.08 27
Price/Book(x) 0 0 0 2.16 1.81 1.57 1.13 2.02 0 6.07 3.26
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.17 0.18 0.2 0.39 0.37 0.31 0.19 0.46 0.18 1.59 0.99
EV/Core EBITDA(x) 4.87 6.19 6.68 11.78 11.25 11.73 3.63 7.36 3.22 22.8 20.39
Net Sales Growth(%) 1.23 17.46 13.67 4.32 -8.66 23.82 60.26 -17.75 23.05 -22.06 9.08
EBIT Growth(%) 42.3 -3.81 12.51 15.91 -12.24 2.61 282.21 -1.43 13.11 -1.86 -23.88
PAT Growth(%) 69.26 -13.67 36.54 44.67 15.18 10.57 471.79 -1.97 7.37 2.54 -25.1
EPS Growth(%) 68.97 -13.7 36.49 -5.94 15.26 10.5 471.9 -1.99 7.37 2.54 -25.11
Debt/Equity(x) 7.76 8.03 7.66 2.13 1.53 1.61 0.86 0.93 0.89 0.31 0.54
Current Ratio(x) 1.14 1.15 1.3 1.73 1.48 1.57 1.92 1.88 1.94 2.44 1.98
Quick Ratio(x) 0.28 0.42 0.19 0.69 0.46 0.41 0.79 0.74 0.57 0.24 0.15
Interest Cover(x) 1.54 1.45 1.66 2 2.45 2.61 18.37 16.82 8.9 15.02 10.84
Total Debt/Mcap(x) 0 0 0 0.98 0.84 1.03 0.76 0.46 0 0.05 0.17

MK Proteins Shareholding Pattern

# Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 74.82 74.82 74.82 74.82 74.82 74.82 74.82 74.82 74.82 74.82
FII 0 0 0 0.02 0.02 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 25.18 25.17 25.18 25.16 25.15 25.17 25.18 25.18 25.18 25.18
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 31% CAGR over last 5 years

Cons

  • Debtor days have increased from 13.74 to 23.45days.
  • Stock is trading at 3.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

MK Proteins News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!